Table 4.
Characteristics of ESRD patients due to DMN and non-DMN related ESRD.
| Variables | Non-DMN-related ESRD patients | DMN-related ESRD patients | p ∗ |
|---|---|---|---|
| Number of subjects | 492 | 179 | |
| SOD2 exon 2 genotype | 0.716 | ||
| TT | 330 (67.1%) | 125 (69.8%) | |
| CT | 150 (30.5%) | 49 (27.4%) | |
| CC | 12 (2.4%) | 5 (2.8%) | |
| GPX1 exon 2 genotype | 0.258 | ||
| CC | 444 (90.2%) | 156 (87.2%) | |
| TC | 48 (9.8%) | 23 (12.8%) | |
| TT | 0 (0.00%) | 0 (0.00%) | |
| PPAR-γ exon B genotype | 0.284 | ||
| CC | 451 (91.7%) | 158 (88.3%) | |
| CG | 37 (7.5%) | 20 (11.2%) | |
| GG | 4 (0.8%) | 1 (0.6%) | |
| PPAR-γ exon 6 genotype | 0.454 | ||
| CC | 263 (53.5%) | 103 (57.5%) | |
| CT | 193 (39.2%) | 61 (34.1%) | |
| TT | 36 (7.3%) | 51 (8.4%) |
∗Continuous variables were tested by Kruskal-Wallis test, whereas categorical variables were tested by Fisher's exact test.